Sinclair MS, Perea-Martinez I, Abouyared M, St John SJ, Chaudhari N
After removing patients with a previous diagnosis of gastroesophageal reflux, those prescribed GLP-1 RAs had a significantly increased risk for chronic cough compared with those prescribed any non-GLP-1 RA, DPP-4 inhibitor, SGLT2 inhibitor, or sulfonylurea (adjusted hazard ratios, 1.29, 1.36, 1.14, and 1.25, respectively)."This cohort study suggests that there is an association between GLP-1 receptor agonist use and new diagnosis of chronic cough," the authors write
HSA and FSA accounts are eligible for reimbursement, and pricing remains flat regardless of dose escalation
However, some people may experience an unpleasant side effect: sulfur burps
The side effects are typically temporary and will fade after a few weeks